NQ
Naureen Quibria Capital One Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Biomea Fusion
BMEA
$114M
| $1.92 | $25 |
1,202%
upside
| Overweight |
29 Aug ‘24
1 year ago |
|
|
IMMP
2
Immutep
IMMP
$242M
| $1.65 | $10 |
506%
upside
| Overweight |
17 May ‘24
1 year ago |
|
3
Erasca
ERAS
$457M
| $1.61 | $8 |
397%
upside
| Overweight |
11 Mar ‘24
1 year ago |
|
4
Carisma Therapeutics
CARM
$16.8M
| $0.4019 | $10 |
2,388%
upside
| Overweight |
3 Oct ‘23
1 year ago |
|
5
Immunocore
IMCR
$1.87B
| $37.20 | $84 |
126%
upside
| Overweight |
16 Aug ‘23
2 years ago |
|
6
Day One Biopharmaceuticals
DAWN
$773M
| $7.55 | $40 |
430%
upside
| Overweight |
8 Feb ‘23
2 years ago |
|
7
Fennec Pharmaceuticals
FENC
$250M
| $9 | $11 |
22%
upside
| Overweight |
7 Sep ‘22
3 years ago |
|
|
GNTA
8
Genenta Science
GNTA
$64M
| $3.50 | $21 |
500%
upside
| Buy |
13 Jan ‘22
3 years ago |
|
|
KZIA
9
Kazia Therapeutics
KZIA
$8.67M
| $7.76 | $900 |
11,498%
upside
| Buy |
14 Oct ‘21
3 years ago |
|